Related Experiment Videos
[Gram-negative rods: antibacterial agents effective on gram-negative rods]
1Laboratory of Drug-resistance in Bacteria, Gunma University School of Medicine.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|February 1, 1994
Summary
Gram-negative rods like Pseudomonas aeruginosa cause severe infections. Antibiotic resistance is a growing concern, with strains resisting gentamicin, new quinolones, and third-generation cephems.
Area of Science:
- Clinical Microbiology
- Infectious Diseases
- Antimicrobial Resistance
Background:
- Gram-negative rods are significant pathogens, particularly in immunocompromised patients.
- Commonly isolated species include Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, Serratia marcescens, and Haemophilus influenzae.
- Several of these species exhibit resistance to multiple antibacterial agents.
Purpose of the Study:
- To investigate the prevalence of antibiotic resistance in clinically significant gram-negative rods.
- To assess the effectiveness of common antibiotics against these resistant strains.
Main Methods:
- Isolation and identification of gram-negative bacterial species from hospital settings.
- Antimicrobial susceptibility testing against various antibiotic classes (aminoglycosides, new quinolones, third-generation cephems, imipenem, cefclidin).
Main Results:
- Pseudomonas aeruginosa, Enterobacter cloacae, and Serratia marcescens demonstrate resistance to numerous antibacterial agents.
- High-frequency resistance to gentamicin observed in P. aeruginosa.
- Emergence of resistance to new quinolones in S. marcescens and P. aeruginosa.
- While third-generation cephems are effective, rapid resistance development occurs.
- Imipenem and cefclidin show effectiveness, though some resistant strains are emerging.
Conclusions:
- Antibiotic resistance is a significant challenge in managing gram-negative rod infections.
- Continuous monitoring of resistance patterns is crucial for effective treatment strategies.
- The emergence of resistance to last-resort antibiotics like imipenem and cefclidin warrants attention.